Impaired apoptosis in lymphoblasts from Alzheimer's disease patients: Cross-talk of Ca2+/calmodulin and ERK1/2 signaling pathways

Cellular and Molecular Life Sciences

Volumn 64, Issue 11, 2007, Pages 1437-1448

  Bartolome F ^a   De Las Cuevas, N ^a,c   Munoz U ^a   Bermejo, F ^b   Martin Requero A ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Alzheimer's disease; Ca2+ calmodulin; Cell survival; ERKs; Lymphocytes

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN);

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LYMPHOBLAST; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CALCIUM; CALMODULIN; CELL LINE; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; ENZYME ACTIVATION; HUMANS; LYMPHOCYTES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 34250013331     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7081-3     Document Type: Article

References (65)

1. McShea, A., Harris, P. L. R, Webster, K. R., Wahl, A. F. and Smith, M. A. (1997) Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 150, 933-939.
2. Nagy, Z. S., Esiri, M. M. and Smith, A. D. (1998) The cell division cycle and the pathophysiology of Alzheimer's disease. Neuroscience 87, 731-739.
3. Busser, J., Geldmacher, D. S. and Herrup, K. (1998) Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 18, 2801-2807.
4. Copani, A., Uberti, D., Sortino, M. A., Bruno, V., Nicoletti, F. and Memo, M. (2001) Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci. 24, 25-31.
5. Yang, Y. Geldmacher, D. S. and Herrup, K. (2001) DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21, 2661-2668.
6. Tatebayashi, Y., Takeda, M., Kashiwagi, Y., Okaochi, M., Kurumadani, T., Sekiyama, A., Kanayama, Q., Hariguchi, S. and Nishimura, T. (1995) Cell-cycle-dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease. Dementia 6, 9-16.
7. Stieler, J. T., Lederer, C., Bruckner, M. K., Wolf, H., Holzer, M., Gertz, H. J. and Arendt, T. (2001) Impairment ofmitogenic activation of peripheral blood lymphocytes in Alzheimer's disease. Neuroreport 12, 3969-3972.
8. Nagy, Z. S., Combrinck, M., Budge, M. and McShane, R. (2002) Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. Neurosci. Lett. 317, 81-84.
9. Dolman, C. L. (1984) Diagnosis of neurometabolic disorders by examination of skin biopsies and lymphocytes. Semin. Diagn. Pathol. 1, 82-97.
10. Neitzel, H. (1986) A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet. 73, 320-326.
11. Beatty, P. R., Krams, S. M. and Martinez, O. M. (1997) Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J. Immunol. 158, 4045-4051.
12. Minami, R., Watanabe, Y., Kudoh, T., Suzuki, M., Oynagi, K., Orii, T. and Nakao, T. (1978) Lysosomal acid hydrolases in established lymphoblastoid cell lines transformed by Epstein-Barr virus, from patients with genetic lysosomal storage diseases. Hum. Genet. 44. 79-87.
13. + exchanger. Neurobiol. Dis. 8, 289-298.
14. kip1 involved in the enhanced proliferation of lymphoblasts from patients with Alzheimer dementia. Neurobiol. Dis. 13, 254-263.
15. Cuevas, N., Muñoz, U., Hermida, O. G. and Martin-Requero, A. (2005) Altered transcriptional regulators in response to serum in immortalized lymphocytes from Alzheimer's disease patients, Neurobiol. Aging 26, 615-624.
16. Ibarreta, D., Gómez-Isla T., Portera-Sánchez, A., Parrilla, R., and Ayuso, M. S. (1995) Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's disease. J. Neurol. Sci. 14, 146-149.
17. Ibarreta, D., Urcelay, E., Parrilla, R. and Ayuso, M. S. (1998) Distinct pH homeostatic features in lymphoblasts from Alzheimer's disease patients. Ann. Neurol. 44, 216-222.
18. Koistinen, P. (1987) Human peripheral blood and bone marrow cell separation using density gradient centrifugation on Lymphoprep and Percoll in haematological diseases. Scand. J. Clin. Lab. Invest. 47, 709-714.
19. Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N., Treon, S. P. and Anderson, K. C. (2002) Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. Blood 99, 4079-4086.
20. Krishan, A. (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66, 188-193.
21. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
22. Zhong, L. T., Kane, D. J. and Bredesen, D. E. (1993) BCL-2 blocks glutamate toxicity in neural cell lines. Brain Res. Mol. Brain Res. 19, 353-355.
23. Cross, T.G., Scheel-Toellner, D., Henriquez, N.V., Deacon, E., Salmon, M. and Lord, J. M. (2000) Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256, 34-41.
24. Braszil, D. P., Park, J. and Hemmings, B. A. (2002) PKB binding proteins. Getting in on the Akt. Cell 111, 293-303.
25. Johnson, G. L. and Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
26. Vlahos, C. J., Matter, W. F., Hui, K. Y. and Brown, R. F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl- 4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269 5241-5248.
27. Frantz, B., Klatt, T., Pang, M., Parsons, J., Rolando, A., Williams, H., Tocci, M. J., O'Keejfe, S. J. and O'Neill, E. A. (1998) The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding, Biochemistry 37, 13846-13853.
28. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J. and Saltiel, A. R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade, Proc. Natl. Acad. Sci. USA 92, 7686-7689.
29. Muñoz, U., Bartolomé, F., Bermejo, F. and Martín-Requero, A. (2007) Enhanced proteasome-dependent degradation of the CDK inhibitor p27kip1 in immortalized lymphocytes from Alzheimer's dementia patients. Neurobiol. Aging. Doi:10.1016/j.neurobiolaging.2007.03.013.
30. Famularo, G., Giacomelli, R., Alesse, E., Cifone, M. G., Morrone, S., Boirivant, M., Danese, C., Perego, M. A., Santoni, A. and Tonietti, G. (1989) Polyclonal B lymphocyte activation in progressive systemic sclerosis. J. Clin. Lab. Immunol. 29, 59-63.
31. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.
32. Pouysségur, J., Volmat, V. and Leonormand, P. (2002) Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling. Biochem. Pharmacol. 64, 755-763.
33. Mórocz, M., Kálmán, J., Juhász, A., Sinkó, I., McGlynn, A. P., Downes, C., Janka, Z. and Raskó, I. (2002) Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease. Neurobiol. Aging 23, 47-53.
34. Uberti, D., Carsana, T., Bernardi, E., Rodella, L., Grigolato, P., Lanni, C., Racchi, M., Govoni, S. and Memo M. (2002) Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients. J. Cell Sci. 115, 3131-3138.
35. Naderi, J., Lopez, C. and Pandey, S. (2006) Chronically increased oxidative stress in fibroblasts from Alzheimer's disease patients causes early senescence and renders resistance to apoptosis by oxidative stress. Mech. Ageing Dev. 127, 25-35.
36. Schindowsli, K., Krazsch, T., Peters, J., Steiner, B., Leutner, S., Touchet, N., Maurer, K., Czech, C., Pradier, L., Frolich, L., Muller, W. E. and Eckert, A. (2003) Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer's disease. Neuromol. Med. 4, 161-178.
37. Mohammad Abdul, H., Sultana, R., Keller, J. N., St Clair, D. K., Markesbery, W. R. and Butterfield, D. A. (2006) Mutations in amyloid protein and presenilin-1-genes increase the basal oxidative stress mediated by amyloid beta-peptide (1-42). HO and kainic acid: implications for Alzheimer's disease. J. Neurochem. 96, 1322-1335.
38. Yano, S., Tokumitsu, H. and Soderling, T. R. (1998) Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396, 584-587.
39. Egea, J., Espinet, C., Soler, R. M., Dolcet, X., Yuste V. J., Encinas, M., Iglesias, M., Rocamora, N. and Comella, J. X. (2001) Neuronal survival induced by neurotrophins requires calmodulin. J. Cell Biol. 154, 585-597.
40. Cheng, A., Wang, S., Yang, D., Xiao, R. and Mattson, M. P. (2003) Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons. J. Biol. Chem. 278, 7591-7599.
41. Deb, T. B., Coticchia, C. M. and Dickson, R. B. (2004) Calmodulin-mediated activation of Akt regulates survival of c-Myc-overexpressing mouse mammary carcinoma cells. J. Biol. Chem. 279, 38903-38911.
42. Yang, B. F., Xiao, C., Roa, H. W., Krammer, P. H. and Hao, C. (2003) Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells. J. Biol. Chem. 278, 7043-7050.
43. Yao, Y. and Tsien, R. Y. (1997) Calcium current activated by depletion of calcium stores in Xenopus oocytes. J. Gen. Physiol. 109, 703-715.
44. Wang, X. Martindale, J. L., and Holbrook, N. J. (2000) Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 275, 39435-39443.
45. Tang, D., Wu, D., Hirao, A., Lahthi, J. M., Liu, L., Mazza, B., Kidd, V. J., Mak, T. W. and Ingram, A. J. (2002) ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277, 12710-12717.
46. Choi, B. K., Choi C. H., Oh, H. L., and Kim, Y. K. (2004) Role of ERK activation in cisplatin-induced apoptosis in A172 human glioma cells. Neurotoxicology 25, 915-924.
47. Tebar, F., Llado, A. and Enrich, C. (2002) Role of calmodulin in the modulation of the MAPK signalling pathway and the transactivation of epidermal growth factor receptor mediated by PKC. FEBS Lett. 517, 206-210.
48. Illario, M., Cavallo, A. L., Bayer, K. U., Di Matola, T., Fenzi, G., Rossi, G. and Vitale, M. (2003) Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation. J. Biol. Chem. 278, 45101-45198.
49. Bosch, M., Gil, J., Bachs, O. and Agell, N. (1998) Calmodulin inhibitor W13 induces sustained activation of ERK2 and expression of p21(cip1). J. Biol. Chem. 273, 22145-22150.
50. Villalonga, P., Lopez-Alcalá, C., Boch, M., Chiloeches, A., Rocamora, N., Gil, J., Marais, R., Marshall, C. J., Bachs, O. and Agell, N. (2001) Calmodulin binds to K-Ras, but not to H- or NRas, and modulates its downstream signaling. Mol. Cell. Biol. 21, 7345-7354.
51. 2+/ calmodulin-dependent protein kinase II. J. Biol. Chem. 279, 17980-17988.
52. Kim, J. H., Liao, D., Lau, L. F. and Huganir, R. L (1998) SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 20, 683-691.
53. Perez-Sala, D., Collado-Escobar, D. and Mollinedo F. (1995) Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease. J. Biol. Chem. 270, 6235-6242.
54. Zhu, X., Lee, H. G., Raina, A. K., Perry, G. and Smith, M. A. (2002) The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 11, 270-281.
55. Derkinderen, P., Enslen, H. and Girault, J. A. (1999) The ERK/MAP-kinases cascade in the nervous system. Neuroreport 10 R24-R34.
56. McShea, A., Zelasko, D. A., Gerst, J. L. and Smith, M. A. (1999) Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Res. 815, 27-242.
57. Knowles, R. B., Chin, J., Ruff, C. T. and Hyman, B. T. (1999) Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neuro-fibrillary tangles: implications for MAP kinase activation in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58. 1090-1098.
58. Wei, W., Wang, X. and Kusiak, J. W. (2002) Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 277, 17849-17656.
59. Pei, J. J., Braak, H., An, W-L., Winblad, B., Cowburn, R. F., Iqbal K. and Grundke-Iqbal, I. (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associatedwith the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res. Mol. Brain Res. 109, 45-55.
60. Zhao, W. Q., Ravindranath, L., Mohamed, A. S., Zohar, O., Chen, G. H., Lyketsos, C. G., Etcheberrigaray, R. and Alkon, D. L. (2002) MAPkinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblasts. Neurobiol. Dis. 11, 166-183.
61. Khan, T. K. and Alkon, D. L. (2006) An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin. Proc. Natl. Acad. Sci. USA 103, 13203-13207.
62. Raina, A. K., Zhu, X., Shimohama, S., Perry, G. and Smith, M. A. (2003) Tipping the apoptotic balance in Alzheimer's disease: The abortosis concept. Cell Biochem. Biophys. 39, 249-255.
63. Jellinger, K. A. (2006) Challenges in neuronal apoptosis. Curr. Alzheimer Res. 3, 377-391.
64. Zhu, X., Castellani, R. J., Takeda, A., Nunomura, A., Atwood, C. S., Perry, G. and Smith, M. A. (2001) Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech. Ageing Dev. 123 39-46.
65. Zhu, X., Raina, A. K., Perry, G. and Smith, M. A. (2004) Alzheimer's disease. The two-hit hypothesis. Lancet Neurol. 3, 219-226.